Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Erlanson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|June 25, 2004
Fragment-based drug discoveryDaniel A Erlanson, Robert S McDowell, Tom O'Brien
Cell Chemical Biology|November 29, 2018
Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal StructuresDaniel A Erlanson, Ben J Davis, Wolfgang Jahnke
Organic Letters|December 1, 2006
Selective reduction of peptide isothiazolidin-3-onesTimothy P Shiau, Daniel A Erlanson, Eric M Gordon
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2013
A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxideYohannes T Ghebremariam, Daniel A Erlanson, John P Cooke
Annual Review of Biophysics and Biomolecular Structure|May 14, 2004
Tethering: fragment-based drug discoveryDaniel A Erlanson, James A Wells, Andrew C Braisted
RSC Medicinal Chemistry|December 23, 2022
Introduction to the themed collection on fragment-based drug discoveryDavid C Rees, Anna K H Hirsch, Daniel A Erlanson
Journal of Biomolecular Screening|March 31, 2012
Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screeningYohannes T Ghebremariam, Daniel A Erlanson, Keisuke Yamada, et al.
Journal of Medicinal Chemistry|October 15, 2016
Fragment-to-Lead Medicinal Chemistry Publications in 2015Christopher N Johnson, Daniel A Erlanson, Christopher W Murray, et al.
Nature Reviews. Drug Discovery|July 16, 2016
Twenty years on: the impact of fragments on drug discoveryDaniel A Erlanson, Stephen W Fesik, Roderick E Hubbard, et al.
Journal of Medicinal Chemistry|November 1, 2017
Fragment-to-Lead Medicinal Chemistry Publications in 2016Christopher N Johnson, Daniel A Erlanson, Wolfgang Jahnke, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|June 25, 2004
Fragment-based drug discoveryDaniel A Erlanson, Robert S McDowell, Tom O'Brien
Cell Chemical Biology|November 29, 2018
Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal StructuresDaniel A Erlanson, Ben J Davis, Wolfgang Jahnke
Organic Letters|December 1, 2006
Selective reduction of peptide isothiazolidin-3-onesTimothy P Shiau, Daniel A Erlanson, Eric M Gordon
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2013
A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxideYohannes T Ghebremariam, Daniel A Erlanson, John P Cooke
Annual Review of Biophysics and Biomolecular Structure|May 14, 2004
Tethering: fragment-based drug discoveryDaniel A Erlanson, James A Wells, Andrew C Braisted
RSC Medicinal Chemistry|December 23, 2022
Introduction to the themed collection on fragment-based drug discoveryDavid C Rees, Anna K H Hirsch, Daniel A Erlanson
Journal of Biomolecular Screening|March 31, 2012
Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screeningYohannes T Ghebremariam, Daniel A Erlanson, Keisuke Yamada, et al.
Journal of Medicinal Chemistry|October 15, 2016
Fragment-to-Lead Medicinal Chemistry Publications in 2015Christopher N Johnson, Daniel A Erlanson, Christopher W Murray, et al.
Nature Reviews. Drug Discovery|July 16, 2016
Twenty years on: the impact of fragments on drug discoveryDaniel A Erlanson, Stephen W Fesik, Roderick E Hubbard, et al.
Journal of Medicinal Chemistry|November 1, 2017
Fragment-to-Lead Medicinal Chemistry Publications in 2016Christopher N Johnson, Daniel A Erlanson, Wolfgang Jahnke, et al.
Pageof 5